DOCSLIB.ORG

A Reference Method for Aspartate and Alanine Transaminases

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Reference Method for Aspartate and Alanine Transaminases J Clin Pathol: first published as 10.1136/jcp.25.11.940 on 1 November 1972. Downloaded from J. clin. Path., 1972, 25, 940-944 Standardization of clinical enzyme assays: a reference method for aspartate and alanine transaminases J. H. WILKINSON, D. N. BARON, D. W. MOSS, AND P. G. WALKER From Charing Cross Hospital Medical School, Royal Free Hospital School ofMedicine, the Royal Postgraduate Medical School, and the Institute of Orthopaedics, London This is the second report produced by the Working such as those proposed in this report. The principles Party set up under the auspices of the Standards Sub- of calibration were discussed in the first report of the group of the Laboratory Development Advisory Working Party. Group of the Department of Health and Social Security. The Working Party includes representatives Principle of the Association of Clinical Biochemists, the Asso- ciation of Clinical Pathologists, and the Royal The reactions involved in the determination of College of Pathologists. Its first report, devoted to aspartate transaminase (AST) activity are as follows: the standardization of the assay of alkaline phos- Aspartate + 2-oxoglutarate glutamate + phatase, has recently been published (Moss, Baron, oxaloacetate .. .. .. *- (1) Walker, and Wilkinson, 1971). malate by copyright. Aspartate and alanine transaminases have long Oxaloacetate + NADH + H + been known in clinical biochemistry as glutamate- dehydrogenase oxaloacetate transaminase and glutamate-pyruvate malate + NAD+ .. (2) transaminase respectively, but are officially recog- The oxaloacetate produced by the transaminase nized by the International Union of Biochemistry as serves as substrate for malate dehydrogenase by L-aspartate: 2-oxoglutarate aminotransferase (EC which it is reduced to malate in the presence of 2.6.1.1.) and L-alanine: 2-oxoglutarate amino- dihydronicotinamide-adenine dinucleotide (NADH), transferase (EC 2.6.1.2.). Aspartate transaminase which is simultaneously oxidized. NADH has an and alanine transaminase are approved trivial names absorbence peak at 340 nm which is not shown by http://jcp.bmj.com/ and in this report these are abbreviated to AST and the oxidized form, and the decrease in absorbence ALT respectively. at this wavelength provides a means for the measure- Several colorimetric, fluorimetric, and spectro- ment of the transaminase activity. The methods photometric techniques have been devised for their suggested are based upon those of Henry, Chiamori, determination but for the purposes of standardiza- Golub, and Berkman (1960) who re-investigated and tion a spectrophotometric procedure is recom- improved the technique originally introduced by mended as a reference method. Karmen (1955). The measurement of aspartate and alanine trans- The spectrophotometric procedure has an im- on September 24, 2021 by guest. Protected aminase activities, described in this report, are portant advantage over colorimetric procedures in examples of reaction-rate techniques in which the which the oxaloacetate produced in reaction 1 progress of the enzyme reaction is followed through- is allowed to react with a chromogenic reagent out the period of observation. Absorbence readings such as 2,4-dinitrophenyl-hydrazine (Reitman are taken at intervals timed with a stopwatch or, and Frankel, 1957) or a diazonium reagent preferably, with the aid of a recording spectropho- (Babson, Shapiro, Williams, and Phillips, 1962). tometer. By such means it can be verified that the Oxaloacetate is a potent inhibitor of AST (Boyd, reaction rate is constant. Such verification is clearly 1961) and in the spectrophotometric procedure is impossible with a two-point assay system. Neverthe- removed as fast as it is formed, whereas in the colori- less, within certain limits methods of the latter type metric techniques it is allowed to accumulate. can be used satisfactorily, provided they are cali- The spectrophotometric procedure is standardized brated with the aid of a suitable reference method, by reference to the molar absorbance of NADH Received for publication 20 September 1972. (6-22 x 103) at 340 nm. The decrease in unit time 940 J Clin Pathol: first published as 10.1136/jcp.25.11.940 on 1 November 1972. Downloaded from Standar-dizationt of clinical enzyme assays: a referenice mtiethod for aspartate amid alamiine tr-ansamninases 941 (1 min) during the rectilinear (zero order) phase of substrate for ALT and in our experience does not the reaction provides a means for the calculation of appear to inhibit the enzyme, DL-alanine may be the enzyme activity in intcrnational units (micro- used in place of L-alanine. The necessary two-fold moles NADH oxidized per minute) per litre' under increase in concentration, however, complicates the the reaction conditions defined. use of the DL-form, which is liable to crystallize Alternatively the NADH may be measured from stock solutions during storage in a refrigerator. fluorimetrically (Laursen and Hansen, 1958), and The reference methods recommended in this this procedure has been adapted to an end-point report are those of Henry et al (1960), slightly system for use in the AutoAnalyzer (Levine and Hill, modified in that measurements are made at 25°C, 1965) but it is unsuitable for use as a reference and a final concentration of 025 moles/litre L- method. alanine is used for the ALT reaction. Similar principles are cmployed in the measure- ment of alanine transaminase (ALT) activity. In the Temperature spectrophotometric procedure (Henley and Pollard, 1955), the pyruvate producAed in the transaminase Karmen (1955) performed his reaction at 'room reaction (3) is reduced to lactate by the NAD+- temperature' (23°C) and Henry et al (1960) specified dependent lactate dehydrogenase (4): 32°C, the temperature reached in the cell compart- Alanine + 2-oxoglutaratte glutamate + ment of the Beckman DU spectrophotometer. The pyruvate .. (3) International Union of Biochemistry originally lactate recommended 25°C, but later 30CC, for enzyme Pyruvate + NADH + H-+ - determination, but few clinical laboratories in dehydrogenase (4) Britain carry out enzyme measurements at 30CC, lactate + NAD+ .. - since in this country it is quite practicable to main- tain a temperature of 25°C in a thermostatically Substrate Concentrations controlled cuvette compartment of a spectropho- tometer for most of the year without the aid of an Henry et al (1960) modified the AST technique by by copyright. adjusting the substrate concentrations to give con external cooling unit other than tap water. The development of semi-automated enzyme rate siderably higher enzyme acd tivitiestivities. ThemLasparttedThe L-aspartatei analyzers, such as the LKB, or spectrophotometers concentration (0-033 moles/litre) employed in specially adapted for microanalysis, such as the Karmen's original spectrophi procedue otometric Eskalab, which operate at or has neces- the determination of AST (Karmen,l1955) was foundford sitated further review of 35°Coperating37CC,temperatures. to be suboptimal, and Heniry et al(1960) recoi- There is much to be gained by performing all NAD- mended increasing this to 0h125 molesitrehi i or NADP-dependent enzyme measurements at a aspartate cannot be used as Ithe D- form inhibits this single temperature, but the Working Party has not transaminase. http://jcp.bmj.com/ Although Henry et al (1'960) increased the final been able to recommend a universally satisfactory concentration of L-alanine to 0.167 moles/litre in temperature. The choice appears to lie between the measurement of ALT activity experience has 250C, 30'C, 35°C, and 37 C. We at first considered as the most suitable, since the phosphatases since shown that this conct entration is suboptimal and37°Cother enzymes are regularly determined at this (Arvan and Coyle, 1969; Laudahn, Hartmann temperature and every clinical laboratory is equip- Rosenfeld, Weyer, and Mtuth 1970). 0Arvan and ped a 37°C water bath. However, doubts were the use of 25 moles/ with Coyle (1969) recommended about the stability of certain enzymes at 37°C, on September 24, 2021 by guest. Protected litre L-alanine, since higher thnentuseiofns asfelt cinenrecommendeds2 byb in particular liver lactate dehydrogenase (LD-5) and the 0 81 moles/litre L-alan While Laudahn et al (1970) ) causedmlte,littlefrecommendfurther enhance-ned glucose 6-phosphate dehydrogenase (GPD). in the Working Party has been unable to obtain evi- ment of activity and led to difficulty preparing dence of loss of activity of the former at 37°C, the stock solutions, owing to t]he limited solubility of latter loses about 15% of its activity during pre- this amino acid. Since D-alI mnine does not act as a incubation for 20 minutes at 37°C. 'The international unit of enzyme a(ctivity (U or iu) has not been The Working Party has some reservations about adapted for use with the SI system (S5 ysteme Internationale d'Unites). proposing a temperature other than that recom- The IUPAC/1UB Commission on Biiochemical Nomenclature have instead recommended the 'katal' as the unit of 'catalytic amount', mended by the International Union of Biochemistry defined as the amount of a catalyst (irncluding an enzyme) that brings and endorsed by the International Federation of about the transformation of one molte of substrate per second under defined conditions. Thus 1 katal perr litre (kat/l) = 60 10' inter- Clinical Chemistry, namely 30'C, but the fact has to national units per litre (U/I) or I U/I -- 1667 nkat/l. be faced that this figure has not proved acceptable hn 2The Boehringer
Load more

Recommended publications
  • Tbamitchodral L Alizaion of the 4Aminobutyrate-2-&Oxoglutarate
    5d.em. J. (lWg77) 161,9O.-307 3O1 Printed in Great Britain Tbamitchodral L alizaion of the 4Aminobutyrate-2-&Oxoglutarate Transminase from Ox Brait By INGER SCHOUSDOE,* BIRGIT 1MO* and ARNE SCHOUSBOEt Department ofBDahemistry At andC*, University ofCopenhagen, 2200 Copenhagen M, Denark (Receved 4 June 1976) In order to determine the intramitochondrial location of 4-aminobutyrate transaminase, mitochondria were prepared from ox brain and freed from myelin and syiaptosomes by using conventional demitygradient-centrifugation techniques, and the purity was checked electron-microscopically. Iner and outer mimbrenes and matrix were prepared from the mitochondria by large-amplitude sweling and subsequent density-gradient centrfugationt The fractions were characterized by using both electron microscopy and differnt marker enzymes. From the specific activity of the 4-aminobutyrate transaminase in the submitochondrial fractions it was concluded that this enzyme is associated with the inner mitochondrial membrane. It is generally agreed that the 4-aminobutyrate-2- pyridoxal phosphate were from Sigma Chemical oxoglutarate transaminase (EC2.6.1.19) from brain is Co., St. Louis, MO, U.S.A. Ficoll was from mainly associated with free mitochondria (Salganicoff Pharmacia, Uppsala, Sweden, and crystallized & De Robertis, 1963, 1965; van den Berget al., 1965; bovine serum albumin was from BDH Biochemicals, van Kempen et at., 1965; Balazs et al., 1966; Poole, Dorset, U.K. 4-Amino[1-'4C]butyrate (sp. Waksman et al., 1968; Reijnierse et al., 1975), radioactivity 50mCi/mmol) and [1-14qtyramine (sp. and a preparation of a crude mitochondrial fraction radioactivity 9mCi/mmol) were obtained from was used by Schousboe et al. (1973) and Maitre et al.
    [Show full text]
  • Causes and Evaluation of Mildly Elevated Liver Transaminase Levels ROBERT C
    Causes and Evaluation of Mildly Elevated Liver Transaminase Levels ROBERT C. OH, LTC, MC, USA, and THOMAS R. HUSTEAD, LTC, MC, USA Tripler Army Medical Center Family Medicine Residency Program, Honolulu, Hawaii Mild elevations in levels of the liver enzymes alanine transaminase and aspartate transaminase are commonly dis- covered in asymptomatic patients in primary care. Evidence to guide the diagnostic workup is limited. If the history and physical examination do not suggest a cause, a stepwise evaluation should be initiated based on the prevalence of diseases that cause mild elevations in transaminase levels. The most common cause is nonalcoholic fatty liver disease, which can affect up to 30 percent of the population. Other common causes include alcoholic liver disease, medication- associated liver injury, viral hepatitis (hepatitis B and C), and hemochromatosis. Less common causes include α1-antitrypsin deficiency, autoimmune hepatitis, and Wilson disease. Extrahepatic conditions (e.g., thyroid disorders, celiac disease, hemolysis, muscle disorders) can also cause elevated liver transaminase levels. Initial testing should include a fasting lipid profile; measurement of glucose, serum iron, and ferritin; total iron-binding capacity; and hepa- titis B surface antigen and hepatitis C virus antibody testing. If test results are normal, a trial of lifestyle modification with observation or further testing for less common causes is appropriate. Additional testing may include ultrasonog- raphy; measurement of α1-antitrypsin and ceruloplasmin; serum protein electrophoresis; and antinuclear antibody, smooth muscle antibody, and liver/kidney microsomal antibody type 1 testing. Referral for further evaluation and possible liver biopsy is recommended if transaminase levels remain elevated for six months or more.
    [Show full text]
  • Neuroleptic Malignant Syndrome: Another Medical Cause of Acute Abdomen T.C.N
    Postgraduate Medical Journal (1989) 65, 653 - 655 Postgrad Med J: first published as 10.1136/pgmj.65.767.653 on 1 September 1989. Downloaded from Missed Diagnosis Neuroleptic malignant syndrome: another medical cause of acute abdomen T.C.N. Lo, M.R. Unwin and I.W. Dymock Department ofMedicine, Stepping Hill Hospital, Stockport, UK. Summary: We present a patient with neuroleptic malignant syndrome and intestinal pseudo- obstruction misdiagnosed as being secondary to septicaemia. The management of the patient is discussed with emphasis on the role of creatine kinase and liver function tests. Introduction Neuroleptic malignant syndrome (NMS) is an occas- (92% neutrophils), serum sodium 130 mmol/l, potas- ional but potentially lethal idiosyncratic complication sium 5.1 mmol/l, urea 8.8 mmol/l, creatinine 79 1tmol/ ofneuroleptic drugs.'"2 By February 1989 the Commit- 1, bilirubin 15 Amol/l, alanine transaminase 837 IU/i tee on Safety of Medicines had received reports of 99 (normal 7-45), aspartate transaminase 392 IU/l (nor- cases. (Committee on Safety of Medicines, personal mal 9-41), gamma glutamyl transferase 15 IU/I (nor- Protected by copyright. Communication). It is thought that the condition is mal <65), alkaline phosphatase 62 IU/I (normal underdiagnosed.34 We report on a case of NMS of 35-125). Serial electrocardiograms showed sinus which the presenting features and therapeutic comp- tachycardia with no acute change. Abdominal X-ray lications occurring during the course of the illness revealed marked gaseous distension ofsmall and large served to further our knowledge in this condition. bowels with multiple fluid levels seen on decubitus films.
    [Show full text]
  • Liver Intracellular L-Cysteine Concentration Is Maintained After Inhibition of the Trans-Sulfuration Pathway by Propargylglycine in Rats
    Downloaded from British Journal of Nutrition (1997), 78, 823-831 823 https://www.cambridge.org/core Liver intracellular L-cysteine concentration is maintained after inhibition of the trans-sulfuration pathway by propargylglycine in rats BY ANA TRIGUERO', TERESA BARBER', CONCHA GARC~A', . IP address: INMACULADA R. PUERTES', JUAN SASTRE~AND JUAN R. VIRA' 'Departamento de Bioquhica y Biologia Molecular and 2Departamento de Fisiologfa, Facultades de Farmucia y Medicina, Universidad de Valencia, 46010-Valencia, Spain 170.106.33.14 (Received 31 January 1997 - Revised 24 April I997 - Accepted 7 May 1997) , on 26 Sep 2021 at 14:28:26 To study the fate of L-cysteine and amino acid homeostasis in liver after the inhibition of the trans- sulfuration pathway, rats were treated with propargylglycine (PPG). At 4 h after the administration of PPG, liver cystathionase (EC 4.4.1.1) activity was undetectable, L-cystathionine levels were significantly higher, L-cysteine was unchanged and GSH concentration was significantly lower than values found in livers from control rats injected intraperitoneally with 0.15 M-NaCl. The hepatic levels of amino acids that are intermediates of the urea cycle, L-ornithine, L-citrulline and L-arginine and blood urea were significantly greater. Urea excretion was also higher in PPG-treated rats when , subject to the Cambridge Core terms of use, available at compared with control rats. These data suggest a stimulation of ureagenesis in PPG-treated rats. The inhibition of y-cystathionase was reflected in the blood levels of amino acids, because the L- methionine :L-cyst(e)ine ratio was significantly higher in PPG-treated rats than in control rats; blood concentration of cystathionine was also greater.
    [Show full text]
  • 69-10599 GOMES, Benedict, 1933
    - - ~- ... - - - .- - _. - - .. ~. - - - I' This dissertation has been 69-10,599 microfilmed exactly as received GOMES, Benedict, 1933- BEEF LIVER MITOCHONDRIAL AMINE OXIDASE; PURIFICATION AND STUDIES ON SOME PHYSICAL AND CHEMICAL PROPERTIES. University of Hawaii, Ph.D., 1968 Biochemistry University Microfilms, Inc., Ann Arbor, Michigan BEEF LIVER MITOCHONDRIAL AMINE OXIDASE; PURIFICATION AND STUDIES ON SOME PHYSICAL AND CHEMICAL PROPERTIES A DISSERTATION SUBMITTED TO THE GRADUATE DIVISION OF THE UNIVERSITY OF HAWAII IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN BIOCHEMISTRY SEPTEMBER 1968 by BENEDICT GOMES Dissertation Committee: Kerry T. Yasunobu, Chairman Morton Mandel Lawrence H. Piette Robert H. McKay John B. Hall DEDICATION TO MY MOTHER Acknowledgements To the East-West Center of the University of Hawaii; the National Institute of Health; and the Hawaii Heart Association for fellowships. To Drs. I. Igaue and H. J. Kloepfer for their assistance in the enzyme purification. To Mrs. Tomi Haehnlen and Kazi Sirazul Islam for drawing figures. TABLE OF CONTENTS LIST OF TABLES ••••••••••••••••••••••.•••••••••• vi LIST OF FIGURES •••••.•.••••••••••.••••••••••••. viii ABBREVIATIONS .••••••.•.•.••••••••••.••••••••••• xi ABSTRACT •..•.•.•.••.•••••••••••••••.••••••••••. xii I. INTRODUCTION. •••.•.•••.••••••••..•••••••••. 1 A. Historical Background of Amine 2 Oxidase Studies •••..••••••••••.•••• B. Physiological Significance •.••••••• 5 C. Statement of the Problem........... 6 II. MATERIALS AND METHODS .•••••••.••••••••••.••
    [Show full text]
  • Independent Effect of Alanine Transaminase on the Incidence Of
    Clinica Chimica Acta 495 (2019) 54–59 Contents lists available at ScienceDirect Clinica Chimica Acta journal homepage: www.elsevier.com/locate/cca Independent effect of alanine transaminase on the incidence of type 2 diabetes mellitus, stratified by age and gender: A secondary analysis based T on a large cohort study in China Feng Gaoa, Xie-lin Huangb, Xue-Pei Jianga, Min Xuea, Ya-Ling Lia, Xin-Ran Lina, Yi-Han Chena, ⁎ Zhi-Ming Huanga, a Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China b Department of Gastroenterology Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China ARTICLE INFO ABSTRACT Keywords: Background: Previous studies have revealed that alanine aminotransferase (ALT) may be one of the risk factors Alanine transaminase of developing diabetes. We aimed to demonstrate the independent effect of ALT on incident diabetes and to Diabetes investigate whether the association between ALT and incident diabetes is modified by age and gender in the Age general Chinese population. Sex Methods: The present study was a retrospective cohort study, including 210,051 Chinese adult participants. The primary outcome was developing diabetes. The serum ALT activities were stratified by quintiles. We obtained data from ‘DATADRYAD’ website and used the data for secondary analysis. Results: At a median follow-up of 3.0 y, 4144 of 210,051 (1.97%) participants developed diabetes. After ad- justment for potential confounders, a significantly higher risk of the incident diabetes (HR: 1.43, 95% CI: 1.25–1.63) was found in participants in the fifth quintile (Q5, ≥31 U/L) compared to those in the first to fourth quintiles (Q1–4) for ALT activities.
    [Show full text]
  • The World Turns to Us
    The world turns to us 2009 Annual Report 75 years and still advancing Company Profi le Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing. Our diagnostic systems are found in hospitals and other critical care settings around the world and produce information used by physicians to diagnose disease, make treatment decisions and monitor patients. Scientists use our life science research instruments to study complex biological problems including causes of disease and potential new therapies or drugs. Hospital laboratories are our core clinical diagnostic customers. Our life science customers include pharmaceutical and biotechnology companies, medical schools and research institutions. Beckman Coulter has an installed base of more than 200,000 clinical and research systems operating in laboratories around the world. About 81% of Beckman Coulter’s $3.3 billion annual revenue comes from recurring sources, such as consumable supplies (including reagent test kits), service and lease payments. Beckman Coulter 2009 Annual Report P1 For 75 years, the world has turned to us to help fi nd answers to the mysteries of medical science. We’re proud to say we’ve solved many of them. Today, with a focus on recurring revenue growth, operating excellence and quality, we are delivering steady results to shareholders even in these uncertain times. Our unwavering dedication to improving patient health and reducing the cost of care defi nes who we are. Our track record of creating the industry’s most productive products and our broad and growing capabilities in the core laboratory clearly position us as a leader in biomedical testing.
    [Show full text]
  • Metabolism of Neoplastic Tissue II. a Survey of Enzymes of the Citric Acid Cycle in Transplanted Tumors*
    Metabolism of Neoplastic Tissue II. A Survey of Enzymes of the Citric Acid Cycle in Transplanted Tumors* CHARLES E. WENNER,t MORRIS A. SPIRTES, AND SIDNEY WEINHOUSE (The Lankenau Hospital Research institute and the Instituiefor Cancer Research, and the Department of Chemistry, Temple University, Philadelphia, Pa.) Recent isotopic tracer studies of tumor metabo on homogenates of the whole tissue or on extracts lism indicated that the neoplastic cell can carry out of acetone powders. All assays were carried out in the complete oxidation of glucose and fatty acids the zero order range of substrate concentration via the citric acid cycle (84, 85). In view of a strong and with proportionality of enzyme activity and body of evidence against the occurrence of the tissue concentration—these conditions having Krebs cycle in tumors (18, 19), further information been established by preliminary experiments. De bearing on this problem seemed desirable. Accord tails of the procedures are given in the individual ingly, a survey was undertaken of various trans sections and in the table headings. The prepara planted neoplasms for their content of citric acid tions of homogenates will be described in the indi cycle enzymes. In order to obtain a “profile―of vidual assays. The acetone powder extracts were enzymatic activity, approximate assays were car prepared as follows : the freshly dissected tissue ned out of those enzymes for which straightfor (pooled from four to six animals) was homogenized ward methods were available; these included for 1 minute at 2°C. in a Waring Blendor with 2 malic, isocitric, and a-ketoglutaric dehydroge volumes of acetone.
    [Show full text]
  • Gamma Glutamyl Transferase (GGT) NCD 190.32
    Medicare National Coverage Determination (NCD) Policy TRANSFERASE GAMMA GLUTAMYL Summary: Gamma Glutamyl Transferase (GGT) NCD 190.32 The terms of Medicare National Coverage Determinations (NCDs) are binding on all fee-for-service (Part A/B) Medicare Administrative Contractors (MACs) and Medicare Advantage (MA) plans. NCDs are not binding, however, on Medicaid and other governmental payers, nor are they binding on commercial payers in their non-MA lines of business. Item/Service Description* Gamma Glutamyl Transferase (GGT) is an intracellular enzyme that appears in blood following leakage from cells. Renal tubules, liver, and pancreas contain high amounts, although the measurement of GGT in serum is almost always used for assessment of hepatobiliary function. Unlike other enzymes which are found in heart, skeletal muscle, and intestinal mucosa as well as liver, the appearance of an elevated level of GGT in serum is almost always the result of liver disease or injury. It is specifically useful to differentiate elevated alkaline phosphatase levels when the source of the alkaline phosphatase increase (bone, liver, or placenta) is unclear. The combination of high alkaline phosphatase and a normal GGT does not, however, rule out liver disease completely. As well as being a very specific marker of hepatobiliary function, GGT is also a very sensitive marker for hepatocellular damage. Abnormal concentrations typically appear before elevations of other liver enzymes or bilirubin are evident. Obstruction of the biliary tract, viral infection (e.g., hepatitis, mononucleosis), metastatic cancer, exposure to hepatotoxins (e.g., organic solvents, drugs, alcohol), and use of drugs that induce microsomal enzymes in the liver (e.g., cimetidine, barbiturates, phenytoin, and carbamazepine) all can cause a moderate to marked increase in GGT serum concentration.
    [Show full text]
  • Como As Enzimas Agem?
    O que são enzimas? Catalizadores biológicos - Aceleram reações químicas específicas sem a formação de produtos colaterais PRODUTO SUBSTRATO COMPLEXO SITIO ATIVO ENZIMA SUBSTRATO Características das enzimas 1 - Grande maioria das enzimas são proteínas (algumas moléculas de RNA tem atividade catalítica) 2 - Funcionam em soluções aquosas diluídas, em condições muito suaves de temperatura e pH (mM, pH neutro, 25 a 37oC) Pepsina estômago – pH 2 Enzimas de organismos hipertermófilos (crescem em ambientes quentes) atuam a 95oC 3 - Apresentam alto grau de especificidade por seus reagentes (substratos) Molécula que se liga ao sítio ativo Região da enzima e que vai sofrer onde ocorre a a ação da reação = sítio ativo enzima = substrato 4 - Peso molecular: varia de 12.000 à 1 milhão daltons (Da), são portanto muito grandes quando comparadas ao substrato. 5 - A atividade catalítica das Enzimas depende da integridade de sua conformação protéica nativa – local de atividade catalítica (sitio ativo) Sítio ativo e toda a molécula proporciona um ambiente adequado para ocorrer a reação química desejada sobre o substrato A atividade de algumas enzimas podem depender de outros componentes não proteicos Enzima ativa = Holoenzimas Parte protéica das enzimas + cofator Apoenzima ou apoproteína •Íon inorgânico •Molécula complexa (coenzima) Covalentemente ligados à apoenzima GRUPO PROSTÉTICO COFATORES Elemento com ação complementar ao sitio ativo as enzimas que auxiliam na formação de um ambiente ideal para ocorrer a reação química ou participam diretamente dela
    [Show full text]
  • The Proteins
    The Proteins The name protein is derived from Greek word Proteioes which means first because proteins essential for growth and maintenance of life. Proteins: are complex nitrogenous polymers present in all living matter, contain C,H,O and nitrogen, also contain sulfur, phosphorous, zinc, copper and iron. -- are made up of hundreds or thousands of smaller units called amino acids which are attached to one another in long chains. -- there are 20 different types of amino acids that can be combined to make a protein. -- the sequence of amino acids determines each protein’s unique 3-dimensional structure and its specific function. We need protein in diet 1. repair cells and make new ones. 2. important for growth and development in children, teens, and pregnant women. Amino acids Amino acids : are organic acids containing an amino group (NH2) and a carboxylic acid (COOH) group. The side chain can be, aliphatic, aromatic, heterocyclic, containing sulphar group . All amino acids are L-amino acids configuration. Proteins are made up of 20 amino acids in different sequences and numbers. Classification: Amino acids are classified into three groups: 1. neutral amino acids: are the largest group which are divided into: a.aliphatic amino acids ( glycine,valine,alanine,leucine,isoleucine). b. aromatic amino acids ( tyrosine, phenylalanine). c. heterocyclic amino acids ( tryptophan, histidine). d. sulpher containing amino acid ( cystine , cysteine , methionine ) 2. Acidic amino acids ( aspartic acid , glutamic acid ) 3. Basic amino acids (Lysine , arginine). Essential amino acids : Amino acids are not synthesized in the body and are essential as constituents of tissue proteins , therefore it must be supplied in food.
    [Show full text]
  • Supplementary Information
    Supplementary information (a) (b) Figure S1. Resistant (a) and sensitive (b) gene scores plotted against subsystems involved in cell regulation. The small circles represent the individual hits and the large circles represent the mean of each subsystem. Each individual score signifies the mean of 12 trials – three biological and four technical. The p-value was calculated as a two-tailed t-test and significance was determined using the Benjamini-Hochberg procedure; false discovery rate was selected to be 0.1. Plots constructed using Pathway Tools, Omics Dashboard. Figure S2. Connectivity map displaying the predicted functional associations between the silver-resistant gene hits; disconnected gene hits not shown. The thicknesses of the lines indicate the degree of confidence prediction for the given interaction, based on fusion, co-occurrence, experimental and co-expression data. Figure produced using STRING (version 10.5) and a medium confidence score (approximate probability) of 0.4. Figure S3. Connectivity map displaying the predicted functional associations between the silver-sensitive gene hits; disconnected gene hits not shown. The thicknesses of the lines indicate the degree of confidence prediction for the given interaction, based on fusion, co-occurrence, experimental and co-expression data. Figure produced using STRING (version 10.5) and a medium confidence score (approximate probability) of 0.4. Figure S4. Metabolic overview of the pathways in Escherichia coli. The pathways involved in silver-resistance are coloured according to respective normalized score. Each individual score represents the mean of 12 trials – three biological and four technical. Amino acid – upward pointing triangle, carbohydrate – square, proteins – diamond, purines – vertical ellipse, cofactor – downward pointing triangle, tRNA – tee, and other – circle.
    [Show full text]